Recall D-0130-2023
Description: Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1
Recall D-0130-2023 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0130-2023 |
| Event ID | 91378 |
| Distribution | Nationwide to medical facilities. |
| Quantity | 11,453 vials |
| Recall Reason | CGMP Deviations: Raw material recalled by repackager, due to discoloration. |
| Drug Classification | Class II |
| Drug Code Info | 20230111 |
| Recall Initiation Date | 20221222 |
| Report Date | 20230111 |
| Classification Date | 20230113 |
| Address | 355 Riverwalk Pkwy Tonawanda, NY 14150-5837 United States |
| Recalling Firm | Pine Pharmaceuticals, LLC |
| Initial Notification | |
| Similar To |